Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 280

1.

CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.

Herling M, Jones D.

Am J Clin Pathol. 2007 May;127(5):687-700. Review.

PMID:
17439829
2.

[Hematodermic CD4/CD56 neoplasm].

Petrella T, Wechsler J, Courville P, de Muret A, Bosq J, Déchelotte P, Feuillard J, Durlach A, Vergier B.

Ann Pathol. 2004 Jun;24(3):241-55; quiz 227. Review. French.

PMID:
15480259
3.

'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes.

Petrella T, Comeau MR, Maynadié M, Couillault G, De Muret A, Maliszewski CR, Dalac S, Durlach A, Galibert L.

Am J Surg Pathol. 2002 Jul;26(7):852-62.

PMID:
12131152
4.

Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms.

Jaye DL, Geigerman CM, Herling M, Eastburn K, Waller EK, Jones D.

Mod Pathol. 2006 Dec;19(12):1555-62. Epub 2006 Sep 22.

5.

TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.

Petrella T, Meijer CJ, Dalac S, Willemze R, Maynadié M, Machet L, Casasnovas O, Vergier B, Teitell MA.

Am J Clin Pathol. 2004 Aug;122(2):307-13.

PMID:
15323148
6.

CD4+/CD56+ Hematodermic neoplasm (plasmacytoid dendritic cell tumor).

Shiman M, Marchione R, Ricotti C, Romanelli P, Alonso-Llamazares J.

Dermatol Online J. 2008 Nov 15;14(11):5. Review.

PMID:
19094843
7.

CD4+ CD56+ haematodermic tumour (plasmacytoid dendritic cell neoplasm).

Hamadani M, Magro CM, Porcu P.

Br J Haematol. 2008 Jan;140(2):122. Epub 2007 Nov 6. No abstract available.

PMID:
17991297
8.

TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin.

Herling M, Teitell MA, Shen RR, Medeiros LJ, Jones D.

Blood. 2003 Jun 15;101(12):5007-9. Epub 2003 Feb 6.

9.

[Agranular CD4+ CD56+ CD123+ hematodermic neoplasm (blastic NK-cell lymphoma) revealed by cutaneous localization: 2 cases].

Machet L, De Muret A, Wiezberka E, Bernez A, Abdallah-Lotf M, Linassier C, Petrella T.

Ann Dermatol Venereol. 2004 Nov;131(11):969-73. French.

PMID:
15602384
10.

Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases.

Ng AP, Lade S, Rutherford T, McCormack C, Prince HM, Westerman DA.

Haematologica. 2006 Jan;91(1):143-4.

11.
12.

[Rare diagnosis of CD4+56+ leukemia from dendritic cells type DC2].

Klabusay M, Pevná M, Kissová J, Doubek M, Heidekerová M, Mayer J, Vorlícek J.

Cas Lek Cesk. 2008;147(10):511-5. Review. Czech.

PMID:
19177732
13.

Clinical and biologic features of CD4(+)CD56(+) malignancies.

Feuillard J, Jacob MC, Valensi F, Maynadié M, Gressin R, Chaperot L, Arnoulet C, Brignole-Baudouin F, Drénou B, Duchayne E, Falkenrodt A, Garand R, Homolle E, Husson B, Kuhlein E, Le Calvez G, Sainty D, Sotto MF, Trimoreau F, Béné MC.

Blood. 2002 Mar 1;99(5):1556-63.

14.

Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review.

Petrella T, Bagot M, Willemze R, Beylot-Barry M, Vergier B, Delaunay M, Meijer CJ, Courville P, Joly P, Grange F, De Muret A, Machet L, Dompmartin A, Bosq J, Durlach A, Bernard P, Dalac S, Dechelotte P, D'Incan M, Wechsler J, Teitell MA.

Am J Clin Pathol. 2005 May;123(5):662-75. Review.

PMID:
15981806
15.

CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype.

Urosevic M, Conrad C, Kamarashev J, Asagoe K, Cozzio A, Burg G, Dummer R.

Hum Pathol. 2005 Sep;36(9):1020-4.

PMID:
16153467
16.

A novel plasmacytoid dendritic cell line, CAL-1, established from a patient with blastic natural killer cell lymphoma.

Maeda T, Murata K, Fukushima T, Sugahara K, Tsuruda K, Anami M, Onimaru Y, Tsukasaki K, Tomonaga M, Moriuchi R, Hasegawa H, Yamada Y, Kamihira S.

Int J Hematol. 2005 Feb;81(2):148-54.

PMID:
15765784
18.

CD4+/CD56+ hematodermic neoplasm: report of a rare variant with a T-cell receptor gene rearrangement.

Stetsenko GY, McFarlane R, Kalus A, Olerud J, Cherian S, Fromm J, George E, Argenyi Z.

J Cutan Pathol. 2008 Jun;35(6):579-84. Epub 2007 Nov 12.

PMID:
18005171
19.

CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.

Khoury JD, Medeiros LJ, Manning JT, Sulak LE, Bueso-Ramos C, Jones D.

Cancer. 2002 May 1;94(9):2401-8.

20.

Cutaneous CD4+ CD56+ hematologic malignancies.

Magro CM, Porcu P, Schaefer J, Erter JW, Furman RR, Shitabata PK, Crowson AN.

J Am Acad Dermatol. 2010 Aug;63(2):292-308. doi: 10.1016/j.jaad.2009.08.044. Epub 2010 Jun 11.

PMID:
20541283

Supplemental Content

Support Center